The Peptide Report
The 3 PM productivity crash isn't a willpower problem—it's a delivery problem. Here's why intranasal absorption is quietly replacing the fourth espresso in high-performance circles.
A new generation of founders, VCs, and C-suite operators is quietly abandoning the caffeine-cortisol cycle. Here's what they're using instead — and why the science is unusually compelling.
Wall Street analysts and executives are quietly rewriting the rules of afternoon cognition. Inside the physiology of the 3PM crash—and the intranasal workaround top performers are using in 2026.
An inside look at the quiet shift among Silicon Valley operators who are trading their third coffee for a two-spray afternoon ritual. Here's the science behind why intranasal peptide delivery is reshaping how executives think about cognitive performance.
A magazine-style feature on the quiet shift among high performers from caffeine to fast-absorbing intranasal formulas. We explore the science of nasal delivery and why a new category of doctor-formulated sprays is reshaping how the C-suite shows up at 3pm.
An inside look at the mid-afternoon cognitive crash quietly reshaping how Wall Street traders and Silicon Valley founders manage peak performance. The unlikely tool circulating through hedge fund desks isn't another energy drink.
